Stock Photo - 19 June 2020, Baden-Wuerttemberg, Tübingen: Peter Kremsner, Director of the Institute for Tropical Medicine at the University Hospital of Tübingen. The new active substance of a Tübingen vaccine study comes from the Tübingen-based company Curevac and was used for the first time today at the Institute for Tropical Medicine at the University Hospital of Tübingen. Photo: Christoph Schmidt/dpa. - Tübingen/Baden-Wuerttemberg/Germany

Stock Photo: 19 June 2020, Baden-Wuerttemberg, Tübingen: Peter Kremsner, Director of the Institute for Tropical Medicine at the University Hospital of Tübingen.

Searchable keywords

Choose multiple keywords